| Financial Year |
March 31 2023 |
| Monetary Funds |
235,112,331.36 |
| Held-for-trading Financial Assets |
190,875,188.69 |
| Notes Receivable |
-- |
| Accounts Receivable |
634,912,003.45 |
| Advances to Suppliers |
74,405,837.99 |
| Other Receivables |
15,426,441.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
939,620,278.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,257,858.20 |
| Total Current Assets |
2,255,184,860.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
393,755.66 |
| Investment Properties |
-- |
| Fixed Assetes |
156,365,559.48 |
| Under-construction Projects |
149,332,924.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,525,041.35 |
| R&D expenses |
-- |
| Goodwill |
378,664,532.12 |
| Long-Term Deferred and Prepaid Expenses |
312,394.46 |
| Deferred Income Tax Assets |
31,981,996.78 |
| Other Non-Current Assets |
10,880,250.44 |
| Sub-Total of Non-Current Assets |
943,586,457.28 |
| Total Assets |
3,198,771,317.45 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
89,180,496.58 |
| Notes Payable |
120,702,972.52 |
| Accounts Payable |
445,568,228.90 |
| Accounts Received In Advance |
2,591,379.96 |
| Employee Compensation Payable |
14,645,754.28 |
| Taxes Payable |
40,914,776.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
106,077,263.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,272,936.77 |
| Other Current Liabilities |
16,972,663.12 |
| Sub-Total of Current Liabilities |
1,701,485,089.11 |
| Long-term Loans |
119,962,551.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,562,728.74 |
| Deferred Income Tax Liabilities |
14,168,518.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,321,548.50 |
| Total Liabilities |
1,887,806,637.61 |
| Paid-In Capital(Or Share Stock) |
300,702,900.00 |
| Capital Surplus |
180,385,344.99 |
| Surplus Reserve |
95,968,927.08 |
| LESS:Treasury Stock |
50,302,449.04 |
| Undistributed Profits |
782,146,731.11 |
| Minority Stockholder's Interest |
2,057,866.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,308,906,813.57 |
| Owner's Equity（Stockholder's Equity） |
1,310,964,679.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,198,771,317.45 |
